instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
What was the administration route of drug 'PEMETREXED'? | Nivolumab-induced Vogt-Koyanagi-Harada-like Syndrome and Adrenocortical Insufficiency with Long-term Survival in a Patient with Non-small-cell Lung Cancer.
A 58-year-old man was diagnosed with lung adenocarcinoma with a tumor proportion score of 10%. After six cycles of second-line chemotherapy with nivolumab, he achie... | Intravenous drip | DrugAdministrationRoute | CC BY-NC-ND | 34092725 | 20,203,291 | 2021-11-15 |
What was the dosage of drug 'CARBOPLATIN'? | Nivolumab-induced Vogt-Koyanagi-Harada-like Syndrome and Adrenocortical Insufficiency with Long-term Survival in a Patient with Non-small-cell Lung Cancer.
A 58-year-old man was diagnosed with lung adenocarcinoma with a tumor proportion score of 10%. After six cycles of second-line chemotherapy with nivolumab, he achie... | AREA UNDER THE CURVE=6, DAY 1 | DrugDosageText | CC BY-NC-ND | 34092725 | 20,195,554 | 2021-11-15 |
What was the dosage of drug 'NIVOLUMAB'? | Nivolumab-induced Vogt-Koyanagi-Harada-like Syndrome and Adrenocortical Insufficiency with Long-term Survival in a Patient with Non-small-cell Lung Cancer.
A 58-year-old man was diagnosed with lung adenocarcinoma with a tumor proportion score of 10%. After six cycles of second-line chemotherapy with nivolumab, he achie... | DAY 1 | DrugDosageText | CC BY-NC-ND | 34092725 | 20,195,554 | 2021-11-15 |
What was the outcome of reaction 'Adrenocorticotropic hormone deficiency'? | Nivolumab-induced Vogt-Koyanagi-Harada-like Syndrome and Adrenocortical Insufficiency with Long-term Survival in a Patient with Non-small-cell Lung Cancer.
A 58-year-old man was diagnosed with lung adenocarcinoma with a tumor proportion score of 10%. After six cycles of second-line chemotherapy with nivolumab, he achie... | Recovering | ReactionOutcome | CC BY-NC-ND | 34092725 | 20,195,554 | 2021-11-15 |
What was the outcome of reaction 'Primary adrenal insufficiency'? | Nivolumab-induced Vogt-Koyanagi-Harada-like Syndrome and Adrenocortical Insufficiency with Long-term Survival in a Patient with Non-small-cell Lung Cancer.
A 58-year-old man was diagnosed with lung adenocarcinoma with a tumor proportion score of 10%. After six cycles of second-line chemotherapy with nivolumab, he achie... | Recovering | ReactionOutcome | CC BY-NC-ND | 34092725 | 20,195,554 | 2021-11-15 |
What was the outcome of reaction 'Vogt-Koyanagi-Harada disease'? | Nivolumab-induced Vogt-Koyanagi-Harada-like Syndrome and Adrenocortical Insufficiency with Long-term Survival in a Patient with Non-small-cell Lung Cancer.
A 58-year-old man was diagnosed with lung adenocarcinoma with a tumor proportion score of 10%. After six cycles of second-line chemotherapy with nivolumab, he achie... | Recovering | ReactionOutcome | CC BY-NC-ND | 34092725 | 20,195,554 | 2021-11-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Metastases to central nervous system'. | Late-onset Pleural and Pericardial Effusion as Immune-related Adverse Events after 94 Cycles of Nivolumab.
A 67-year-old man with primary lung adenocarcinoma was hospitalized due to massive bilateral pleural effusion and pericardial effusion after 94 cycles of nivolumab therapy. We were unable to identify the cause of ... | DOCETAXEL, PEMETREXED | DrugsGivenReaction | CC BY-NC-ND | 34092733 | 20,179,091 | 2021-11-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Protein-losing gastroenteropathy'. | Cyclophosphamide-associated enteritis presenting with severe protein-losing enteropathy in granulomatosis with polyangiitis: A case report.
BACKGROUND
Although cyclophosphamide (CPA) is the key drug for the treatment of autoimmune diseases including vasculitides, it has some well-known adverse effects, such as myelosup... | CYCLOPHOSPHAMIDE, METHYLPREDNISOLONE, PREDNISOLONE | DrugsGivenReaction | CC BY-NC | 34092982 | 20,115,131 | 2021-05-28 |
What was the administration route of drug 'CYCLOPHOSPHAMIDE'? | Cyclophosphamide-associated enteritis presenting with severe protein-losing enteropathy in granulomatosis with polyangiitis: A case report.
BACKGROUND
Although cyclophosphamide (CPA) is the key drug for the treatment of autoimmune diseases including vasculitides, it has some well-known adverse effects, such as myelosup... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 34092982 | 20,115,131 | 2021-05-28 |
What was the dosage of drug 'CYCLOPHOSPHAMIDE'? | Cyclophosphamide-associated enteritis presenting with severe protein-losing enteropathy in granulomatosis with polyangiitis: A case report.
BACKGROUND
Although cyclophosphamide (CPA) is the key drug for the treatment of autoimmune diseases including vasculitides, it has some well-known adverse effects, such as myelosup... | 500 MG/MONTH | DrugDosageText | CC BY-NC | 34092982 | 20,115,131 | 2021-05-28 |
What was the outcome of reaction 'Protein-losing gastroenteropathy'? | Cyclophosphamide-associated enteritis presenting with severe protein-losing enteropathy in granulomatosis with polyangiitis: A case report.
BACKGROUND
Although cyclophosphamide (CPA) is the key drug for the treatment of autoimmune diseases including vasculitides, it has some well-known adverse effects, such as myelosup... | Recovering | ReactionOutcome | CC BY-NC | 34092982 | 20,115,131 | 2021-05-28 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Anaemia'. | Real-World, Single-Center Data for Lenalidomide Plus Rituximab in Relapsed or Refractory Diffuse Large B-Cell Lymphoma and Transformed Follicular Lymphoma.
This study explored the efficacy of lenalidomide plus rituximab for patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) including cases of se... | ASPIRIN, LENALIDOMIDE, RITUXIMAB | DrugsGivenReaction | CC BY-NC | 34093038 | 19,445,533 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Bacteraemia'. | Real-World, Single-Center Data for Lenalidomide Plus Rituximab in Relapsed or Refractory Diffuse Large B-Cell Lymphoma and Transformed Follicular Lymphoma.
This study explored the efficacy of lenalidomide plus rituximab for patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) including cases of se... | ASPIRIN, LENALIDOMIDE, RITUXIMAB | DrugsGivenReaction | CC BY-NC | 34093038 | 19,445,533 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Blood albumin decreased'. | Real-World, Single-Center Data for Lenalidomide Plus Rituximab in Relapsed or Refractory Diffuse Large B-Cell Lymphoma and Transformed Follicular Lymphoma.
This study explored the efficacy of lenalidomide plus rituximab for patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) including cases of se... | ASPIRIN, LENALIDOMIDE, RITUXIMAB | DrugsGivenReaction | CC BY-NC | 34093038 | 19,445,533 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Blood creatinine increased'. | Real-World, Single-Center Data for Lenalidomide Plus Rituximab in Relapsed or Refractory Diffuse Large B-Cell Lymphoma and Transformed Follicular Lymphoma.
This study explored the efficacy of lenalidomide plus rituximab for patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) including cases of se... | ASPIRIN, LENALIDOMIDE, RITUXIMAB | DrugsGivenReaction | CC BY-NC | 34093038 | 19,445,533 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease progression'. | Real-World, Single-Center Data for Lenalidomide Plus Rituximab in Relapsed or Refractory Diffuse Large B-Cell Lymphoma and Transformed Follicular Lymphoma.
This study explored the efficacy of lenalidomide plus rituximab for patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) including cases of se... | ASPIRIN, LENALIDOMIDE, RITUXIMAB | DrugsGivenReaction | CC BY-NC | 34093038 | 19,445,533 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Herpes zoster'. | Real-World, Single-Center Data for Lenalidomide Plus Rituximab in Relapsed or Refractory Diffuse Large B-Cell Lymphoma and Transformed Follicular Lymphoma.
This study explored the efficacy of lenalidomide plus rituximab for patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) including cases of se... | ASPIRIN, LENALIDOMIDE, RITUXIMAB | DrugsGivenReaction | CC BY-NC | 34093038 | 19,445,533 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Nephropathy toxic'. | Real-World, Single-Center Data for Lenalidomide Plus Rituximab in Relapsed or Refractory Diffuse Large B-Cell Lymphoma and Transformed Follicular Lymphoma.
This study explored the efficacy of lenalidomide plus rituximab for patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) including cases of se... | ASPIRIN, LENALIDOMIDE, RITUXIMAB | DrugsGivenReaction | CC BY-NC | 34093038 | 19,445,533 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neutropenia'. | Real-World, Single-Center Data for Lenalidomide Plus Rituximab in Relapsed or Refractory Diffuse Large B-Cell Lymphoma and Transformed Follicular Lymphoma.
This study explored the efficacy of lenalidomide plus rituximab for patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) including cases of se... | ASPIRIN, LENALIDOMIDE, RITUXIMAB | DrugsGivenReaction | CC BY-NC | 34093038 | 19,445,533 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Thrombocytopenia'. | Real-World, Single-Center Data for Lenalidomide Plus Rituximab in Relapsed or Refractory Diffuse Large B-Cell Lymphoma and Transformed Follicular Lymphoma.
This study explored the efficacy of lenalidomide plus rituximab for patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) including cases of se... | ASPIRIN, LENALIDOMIDE, RITUXIMAB | DrugsGivenReaction | CC BY-NC | 34093038 | 19,445,533 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Treatment failure'. | Real-World, Single-Center Data for Lenalidomide Plus Rituximab in Relapsed or Refractory Diffuse Large B-Cell Lymphoma and Transformed Follicular Lymphoma.
This study explored the efficacy of lenalidomide plus rituximab for patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) including cases of se... | ASPIRIN, LENALIDOMIDE, RITUXIMAB | DrugsGivenReaction | CC BY-NC | 34093038 | 19,445,533 | 2021 |
What was the administration route of drug 'RITUXIMAB'? | Real-World, Single-Center Data for Lenalidomide Plus Rituximab in Relapsed or Refractory Diffuse Large B-Cell Lymphoma and Transformed Follicular Lymphoma.
This study explored the efficacy of lenalidomide plus rituximab for patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) including cases of se... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 34093038 | 19,445,533 | 2021 |
What was the dosage of drug 'ASPIRIN'? | Real-World, Single-Center Data for Lenalidomide Plus Rituximab in Relapsed or Refractory Diffuse Large B-Cell Lymphoma and Transformed Follicular Lymphoma.
This study explored the efficacy of lenalidomide plus rituximab for patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) including cases of se... | 100 MG | DrugDosageText | CC BY-NC | 34093038 | 19,445,533 | 2021 |
What was the dosage of drug 'LENALIDOMIDE'? | Real-World, Single-Center Data for Lenalidomide Plus Rituximab in Relapsed or Refractory Diffuse Large B-Cell Lymphoma and Transformed Follicular Lymphoma.
This study explored the efficacy of lenalidomide plus rituximab for patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) including cases of se... | 25 MG PER DAY FOR 21 DAYS OF EACH 28?DAY CYCLE | DrugDosageText | CC BY-NC | 34093038 | 19,445,533 | 2021 |
What was the dosage of drug 'RITUXIMAB'? | Real-World, Single-Center Data for Lenalidomide Plus Rituximab in Relapsed or Refractory Diffuse Large B-Cell Lymphoma and Transformed Follicular Lymphoma.
This study explored the efficacy of lenalidomide plus rituximab for patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) including cases of se... | 375 MG/M2 ON DAYS 1, 8, 15, AND 22 ON DAY AT THE 1ST CYCLE, THEN D1 EVERY CYCLE (RANGE: 1?7 CYCLES, | DrugDosageText | CC BY-NC | 34093038 | 19,445,533 | 2021 |
What was the outcome of reaction 'Disease progression'? | Real-World, Single-Center Data for Lenalidomide Plus Rituximab in Relapsed or Refractory Diffuse Large B-Cell Lymphoma and Transformed Follicular Lymphoma.
This study explored the efficacy of lenalidomide plus rituximab for patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) including cases of se... | Fatal | ReactionOutcome | CC BY-NC | 34093038 | 19,445,533 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Case Report: Bilateral Palsy of the Vocal Cords After COVID-19 Infection.
During the COVID-19 pandemic, adverse neurological effects have been described. In addition to unspecific neurological symptoms, cranial nerve deficits have appeared as part of SARS-CoV-2 infection. In this case report, we describe a 74-year-old ... | CLARITHROMYCIN, HYDROXYCHLOROQUINE, METHYLPREDNISOLONE | DrugsGivenReaction | CC BY | 34093389 | 20,215,882 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Vocal cord paralysis'. | Case Report: Bilateral Palsy of the Vocal Cords After COVID-19 Infection.
During the COVID-19 pandemic, adverse neurological effects have been described. In addition to unspecific neurological symptoms, cranial nerve deficits have appeared as part of SARS-CoV-2 infection. In this case report, we describe a 74-year-old ... | METHYLPREDNISOLONE | DrugsGivenReaction | CC BY | 34093389 | 20,217,162 | 2021 |
What was the administration route of drug 'METHYLPREDNISOLONE'? | Case Report: Bilateral Palsy of the Vocal Cords After COVID-19 Infection.
During the COVID-19 pandemic, adverse neurological effects have been described. In addition to unspecific neurological symptoms, cranial nerve deficits have appeared as part of SARS-CoV-2 infection. In this case report, we describe a 74-year-old ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34093389 | 20,221,336 | 2021 |
What was the outcome of reaction 'Vocal cord paralysis'? | Case Report: Bilateral Palsy of the Vocal Cords After COVID-19 Infection.
During the COVID-19 pandemic, adverse neurological effects have been described. In addition to unspecific neurological symptoms, cranial nerve deficits have appeared as part of SARS-CoV-2 infection. In this case report, we describe a 74-year-old ... | Recovering | ReactionOutcome | CC BY | 34093389 | 20,217,162 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hepatic function abnormal'. | Case Report: A Rare Case of Autoinflammatory Phospholipase Cγ2 (PLCγ2)-Associated Antibody Deficiency and Immune Dysregulation Complicated With Gangrenous Pyoderma and Literature Review.
Autoinflammatory phospholipase Cγ2 (PLCγ2)-associated antibody deficiency and immune dysregulation (APLAID) is a rare autoinflammator... | CYCLOSPORINE, METHOTREXATE, PREDNISONE, THALIDOMIDE | DrugsGivenReaction | CC BY | 34093563 | 19,923,663 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Liver injury'. | Case Report: A Rare Case of Autoinflammatory Phospholipase Cγ2 (PLCγ2)-Associated Antibody Deficiency and Immune Dysregulation Complicated With Gangrenous Pyoderma and Literature Review.
Autoinflammatory phospholipase Cγ2 (PLCγ2)-associated antibody deficiency and immune dysregulation (APLAID) is a rare autoinflammator... | CYCLOSPORINE, METHOTREXATE, PREDNISONE, THALIDOMIDE | DrugsGivenReaction | CC BY | 34093563 | 19,923,663 | 2021 |
What was the dosage of drug 'METHOTREXATE'? | Case Report: A Rare Case of Autoinflammatory Phospholipase Cγ2 (PLCγ2)-Associated Antibody Deficiency and Immune Dysregulation Complicated With Gangrenous Pyoderma and Literature Review.
Autoinflammatory phospholipase Cγ2 (PLCγ2)-associated antibody deficiency and immune dysregulation (APLAID) is a rare autoinflammator... | 12.5 mg (milligrams). | DrugDosage | CC BY | 34093563 | 19,923,663 | 2021 |
What was the dosage of drug 'PREDNISONE'? | Case Report: A Rare Case of Autoinflammatory Phospholipase Cγ2 (PLCγ2)-Associated Antibody Deficiency and Immune Dysregulation Complicated With Gangrenous Pyoderma and Literature Review.
Autoinflammatory phospholipase Cγ2 (PLCγ2)-associated antibody deficiency and immune dysregulation (APLAID) is a rare autoinflammator... | 60 mg (milligrams). | DrugDosage | CC BY | 34093563 | 19,923,663 | 2021 |
What was the outcome of reaction 'Hepatic function abnormal'? | Case Report: A Rare Case of Autoinflammatory Phospholipase Cγ2 (PLCγ2)-Associated Antibody Deficiency and Immune Dysregulation Complicated With Gangrenous Pyoderma and Literature Review.
Autoinflammatory phospholipase Cγ2 (PLCγ2)-associated antibody deficiency and immune dysregulation (APLAID) is a rare autoinflammator... | Recovering | ReactionOutcome | CC BY | 34093563 | 19,923,663 | 2021 |
What was the outcome of reaction 'Liver injury'? | Case Report: A Rare Case of Autoinflammatory Phospholipase Cγ2 (PLCγ2)-Associated Antibody Deficiency and Immune Dysregulation Complicated With Gangrenous Pyoderma and Literature Review.
Autoinflammatory phospholipase Cγ2 (PLCγ2)-associated antibody deficiency and immune dysregulation (APLAID) is a rare autoinflammator... | Recovering | ReactionOutcome | CC BY | 34093563 | 19,923,663 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Case Report: Identification of a de novo Microdeletion 1q44 in a Patient With Seizures and Developmental Delay.
Objective: 1q44 microdeletion syndrome is difficult to diagnose due to the wide phenotypic spectrum and strong genetic heterogeneity. We explore the correlation between the chromosome microdeletions and pheno... | TOPIRAMATE | DrugsGivenReaction | CC BY | 34093647 | 19,789,086 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Petit mal epilepsy'. | Case Report: Identification of a de novo Microdeletion 1q44 in a Patient With Seizures and Developmental Delay.
Objective: 1q44 microdeletion syndrome is difficult to diagnose due to the wide phenotypic spectrum and strong genetic heterogeneity. We explore the correlation between the chromosome microdeletions and pheno... | TOPIRAMATE | DrugsGivenReaction | CC BY | 34093647 | 19,789,086 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Deep vein thrombosis'. | Massive thrombosis and phlegmasia cerulea dolens while taking rivaroxaban: case report and review.
Our study describes a fatal case of phlegmasia cerulea dolens and massive venous thrombosis in a patient taking rivaroxaban regularly to treat cerebral venous sinus thrombosis. Blood tests samples were positive for lupus ... | HYDROCHLOROTHIAZIDE, PHENYTOIN, RIVAROXABAN | DrugsGivenReaction | CC BY | 34093674 | 19,413,915 | 2021-04-28 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Massive thrombosis and phlegmasia cerulea dolens while taking rivaroxaban: case report and review.
Our study describes a fatal case of phlegmasia cerulea dolens and massive venous thrombosis in a patient taking rivaroxaban regularly to treat cerebral venous sinus thrombosis. Blood tests samples were positive for lupus ... | HYDROCHLOROTHIAZIDE, PHENYTOIN, RIVAROXABAN | DrugsGivenReaction | CC BY | 34093674 | 19,413,915 | 2021-04-28 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapy partial responder'. | Massive thrombosis and phlegmasia cerulea dolens while taking rivaroxaban: case report and review.
Our study describes a fatal case of phlegmasia cerulea dolens and massive venous thrombosis in a patient taking rivaroxaban regularly to treat cerebral venous sinus thrombosis. Blood tests samples were positive for lupus ... | NOREPINEPHRINE | DrugsGivenReaction | CC BY | 34093674 | 20,236,140 | 2021-04-28 |
What was the administration route of drug 'RIVAROXABAN'? | Massive thrombosis and phlegmasia cerulea dolens while taking rivaroxaban: case report and review.
Our study describes a fatal case of phlegmasia cerulea dolens and massive venous thrombosis in a patient taking rivaroxaban regularly to treat cerebral venous sinus thrombosis. Blood tests samples were positive for lupus ... | Oral | DrugAdministrationRoute | CC BY | 34093674 | 19,413,915 | 2021-04-28 |
What was the outcome of reaction 'Deep vein thrombosis'? | Massive thrombosis and phlegmasia cerulea dolens while taking rivaroxaban: case report and review.
Our study describes a fatal case of phlegmasia cerulea dolens and massive venous thrombosis in a patient taking rivaroxaban regularly to treat cerebral venous sinus thrombosis. Blood tests samples were positive for lupus ... | Fatal | ReactionOutcome | CC BY | 34093674 | 19,413,915 | 2021-04-28 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Febrile neutropenia'. | Next-generation genome sequencing of a matched normal-tumor pair from a patient with intractable gestational choriocarcinoma: A case report.
Gestational choriocarcinoma is a gestational trophoblastic neoplasia (GTN) originating from trophoblastic cells with abnormal proliferation. Although chemotherapy is effective for... | CISPLATIN, DACTINOMYCIN, ETOPOSIDE, METHOTREXATE | DrugsGivenReaction | CC BY-NC-ND | 34094541 | 19,967,174 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pancytopenia'. | Next-generation genome sequencing of a matched normal-tumor pair from a patient with intractable gestational choriocarcinoma: A case report.
Gestational choriocarcinoma is a gestational trophoblastic neoplasia (GTN) originating from trophoblastic cells with abnormal proliferation. Although chemotherapy is effective for... | CISPLATIN, DACTINOMYCIN, ETOPOSIDE, METHOTREXATE | DrugsGivenReaction | CC BY-NC-ND | 34094541 | 19,967,174 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Gastrointestinal disorder'. | Bosutinib-associated interstitial lung disease and pleural effusion: A case report and literature review.
Bosutinib is a tyrosine kinase inhibitor approved for the management of chronic myeloid leukemia (CML). Interstitial lung disease and pleural effusion are pulmonary side effects of TKIs rarely associated with bosut... | DASATINIB, NILOTINIB | DrugsGivenReaction | CC BY | 34094551 | 19,806,754 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Interstitial lung disease'. | Bosutinib-associated interstitial lung disease and pleural effusion: A case report and literature review.
Bosutinib is a tyrosine kinase inhibitor approved for the management of chronic myeloid leukemia (CML). Interstitial lung disease and pleural effusion are pulmonary side effects of TKIs rarely associated with bosut... | BOSUTINIB, PANTOPRAZOLE | DrugsGivenReaction | CC BY | 34094551 | 19,278,330 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pleural effusion'. | Bosutinib-associated interstitial lung disease and pleural effusion: A case report and literature review.
Bosutinib is a tyrosine kinase inhibitor approved for the management of chronic myeloid leukemia (CML). Interstitial lung disease and pleural effusion are pulmonary side effects of TKIs rarely associated with bosut... | BOSUTINIB, PANTOPRAZOLE | DrugsGivenReaction | CC BY | 34094551 | 19,278,330 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Skin disorder'. | Bosutinib-associated interstitial lung disease and pleural effusion: A case report and literature review.
Bosutinib is a tyrosine kinase inhibitor approved for the management of chronic myeloid leukemia (CML). Interstitial lung disease and pleural effusion are pulmonary side effects of TKIs rarely associated with bosut... | DASATINIB, NILOTINIB | DrugsGivenReaction | CC BY | 34094551 | 19,806,754 | 2021-05 |
What was the administration route of drug 'BOSUTINIB'? | Bosutinib-associated interstitial lung disease and pleural effusion: A case report and literature review.
Bosutinib is a tyrosine kinase inhibitor approved for the management of chronic myeloid leukemia (CML). Interstitial lung disease and pleural effusion are pulmonary side effects of TKIs rarely associated with bosut... | Oral | DrugAdministrationRoute | CC BY | 34094551 | 19,278,330 | 2021-05 |
What was the dosage of drug 'DASATINIB'? | Bosutinib-associated interstitial lung disease and pleural effusion: A case report and literature review.
Bosutinib is a tyrosine kinase inhibitor approved for the management of chronic myeloid leukemia (CML). Interstitial lung disease and pleural effusion are pulmonary side effects of TKIs rarely associated with bosut... | 2?MONTH COURSE OF DASATINIB | DrugDosageText | CC BY | 34094551 | 19,806,754 | 2021-05 |
What was the dosage of drug 'NILOTINIB'? | Bosutinib-associated interstitial lung disease and pleural effusion: A case report and literature review.
Bosutinib is a tyrosine kinase inhibitor approved for the management of chronic myeloid leukemia (CML). Interstitial lung disease and pleural effusion are pulmonary side effects of TKIs rarely associated with bosut... | 4?MONTH COURSE OF NILOTINIB | DrugDosageText | CC BY | 34094551 | 19,806,754 | 2021-05 |
What was the outcome of reaction 'Interstitial lung disease'? | Bosutinib-associated interstitial lung disease and pleural effusion: A case report and literature review.
Bosutinib is a tyrosine kinase inhibitor approved for the management of chronic myeloid leukemia (CML). Interstitial lung disease and pleural effusion are pulmonary side effects of TKIs rarely associated with bosut... | Recovered | ReactionOutcome | CC BY | 34094551 | 19,278,330 | 2021-05 |
What was the outcome of reaction 'Pleural effusion'? | Bosutinib-associated interstitial lung disease and pleural effusion: A case report and literature review.
Bosutinib is a tyrosine kinase inhibitor approved for the management of chronic myeloid leukemia (CML). Interstitial lung disease and pleural effusion are pulmonary side effects of TKIs rarely associated with bosut... | Recovered | ReactionOutcome | CC BY | 34094551 | 19,278,330 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Delusion'. | Intramuscular clozapine in the acute medical hospital: Experiences from a liaison psychiatry team.
We present two cases demonstrating safe and effective use of intramuscular clozapine for patients who are physically unwell in acute medical care settings. Both patients described were admitted to inpatient medical care u... | CLOZAPINE | DrugsGivenReaction | CC BY-NC | 34094561 | 19,840,492 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Treatment noncompliance'. | Intramuscular clozapine in the acute medical hospital: Experiences from a liaison psychiatry team.
We present two cases demonstrating safe and effective use of intramuscular clozapine for patients who are physically unwell in acute medical care settings. Both patients described were admitted to inpatient medical care u... | CLOZAPINE | DrugsGivenReaction | CC BY-NC | 34094561 | 19,840,492 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Nail bed bleeding'. | An arm and a leg: A case of rheumatoid vasculitis and antiphospholipid antibody syndrome.
Rheumatoid vasculitis is a rare extra-articular complication of rheumatoid arthritis. The most common manifestation is cutaneous; however, it can manifest in various organ systems and is associated with a high degree of morbidity ... | APIXABAN | DrugsGivenReaction | CC BY-NC | 34094564 | 19,610,629 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Small cell lung cancer extensive stage'. | Development of second primary small-cell lung cancer within the irradiated field after chemoradiotherapy: a report of two cases.
Two male smokers developed small-cell lung cancer (SCLC) as the second primary malignancy (SPM) in the irradiated field after concurrent chemoradiotherapy for locally advanced cancer, which c... | AMRUBICIN, CARBOPLATIN, CISPLATIN, FLUOROURACIL, IRINOTECAN | DrugsGivenReaction | CC BY | 34094568 | 19,650,776 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Small cell lung cancer'. | Development of second primary small-cell lung cancer within the irradiated field after chemoradiotherapy: a report of two cases.
Two male smokers developed small-cell lung cancer (SCLC) as the second primary malignancy (SPM) in the irradiated field after concurrent chemoradiotherapy for locally advanced cancer, which c... | AMRUBICIN, CARBOPLATIN, CISPLATIN, GIMERACIL\OTERACIL\TEGAFUR, IRINOTECAN | DrugsGivenReaction | CC BY | 34094568 | 19,650,780 | 2021-06 |
What was the administration route of drug 'CARBOPLATIN'? | Development of second primary small-cell lung cancer within the irradiated field after chemoradiotherapy: a report of two cases.
Two male smokers developed small-cell lung cancer (SCLC) as the second primary malignancy (SPM) in the irradiated field after concurrent chemoradiotherapy for locally advanced cancer, which c... | Intravenous drip | DrugAdministrationRoute | CC BY | 34094568 | 19,621,917 | 2021-06 |
What was the dosage of drug 'AMRUBICIN'? | Development of second primary small-cell lung cancer within the irradiated field after chemoradiotherapy: a report of two cases.
Two male smokers developed small-cell lung cancer (SCLC) as the second primary malignancy (SPM) in the irradiated field after concurrent chemoradiotherapy for locally advanced cancer, which c... | RECEIVED 5 COURSES | DrugDosageText | CC BY | 34094568 | 19,621,917 | 2021-06 |
What was the dosage of drug 'CARBOPLATIN'? | Development of second primary small-cell lung cancer within the irradiated field after chemoradiotherapy: a report of two cases.
Two male smokers developed small-cell lung cancer (SCLC) as the second primary malignancy (SPM) in the irradiated field after concurrent chemoradiotherapy for locally advanced cancer, which c... | RECEIVED 4 COURSES | DrugDosageText | CC BY | 34094568 | 19,621,917 | 2021-06 |
What was the dosage of drug 'IRINOTECAN'? | Development of second primary small-cell lung cancer within the irradiated field after chemoradiotherapy: a report of two cases.
Two male smokers developed small-cell lung cancer (SCLC) as the second primary malignancy (SPM) in the irradiated field after concurrent chemoradiotherapy for locally advanced cancer, which c... | RECEIVED 4 COURSES | DrugDosageText | CC BY | 34094568 | 19,621,917 | 2021-06 |
What was the outcome of reaction 'Drug ineffective'? | Development of second primary small-cell lung cancer within the irradiated field after chemoradiotherapy: a report of two cases.
Two male smokers developed small-cell lung cancer (SCLC) as the second primary malignancy (SPM) in the irradiated field after concurrent chemoradiotherapy for locally advanced cancer, which c... | Fatal | ReactionOutcome | CC BY | 34094568 | 19,621,917 | 2021-06 |
What was the outcome of reaction 'Small cell lung cancer extensive stage'? | Development of second primary small-cell lung cancer within the irradiated field after chemoradiotherapy: a report of two cases.
Two male smokers developed small-cell lung cancer (SCLC) as the second primary malignancy (SPM) in the irradiated field after concurrent chemoradiotherapy for locally advanced cancer, which c... | Fatal | ReactionOutcome | CC BY | 34094568 | 19,650,776 | 2021-06 |
What was the outcome of reaction 'Small cell lung cancer'? | Development of second primary small-cell lung cancer within the irradiated field after chemoradiotherapy: a report of two cases.
Two male smokers developed small-cell lung cancer (SCLC) as the second primary malignancy (SPM) in the irradiated field after concurrent chemoradiotherapy for locally advanced cancer, which c... | Fatal | ReactionOutcome | CC BY | 34094568 | 19,650,780 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cytomegalovirus infection'. | Pulmonary lymphomatoid granulomatosis: An uncommon disease but not to be forgotten-a single centre experience.
Pulmonary lymphomatoid granulomatosis (PLG) is a rare multisystem Epstein-Barr virus (EBV)-associated lymphoproliferative disorder. Exact incidence is unknown and, with its variable clinical presentation, maki... | CYCLOPHOSPHAMIDE, DOXORUBICIN, HYDROCORTISONE, METHOTREXATE, METHYLPREDNISOLONE, MYCOPHENOLIC ACID, PREDNISOLONE, RITUXIMAB, VINCRISTINE | DrugsGivenReaction | CC BY-NC-ND | 34094574 | 20,460,491 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease progression'. | Pulmonary lymphomatoid granulomatosis: An uncommon disease but not to be forgotten-a single centre experience.
Pulmonary lymphomatoid granulomatosis (PLG) is a rare multisystem Epstein-Barr virus (EBV)-associated lymphoproliferative disorder. Exact incidence is unknown and, with its variable clinical presentation, maki... | AZITHROMYCIN, CEFTRIAXONE, HYDROCORTISONE, METHYLPREDNISOLONE, PIPERACILLIN SODIUM\TAZOBACTAM SODIUM, VANCOMYCIN | DrugsGivenReaction | CC BY-NC-ND | 34094574 | 20,483,428 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Epstein-Barr virus infection'. | Pulmonary lymphomatoid granulomatosis: An uncommon disease but not to be forgotten-a single centre experience.
Pulmonary lymphomatoid granulomatosis (PLG) is a rare multisystem Epstein-Barr virus (EBV)-associated lymphoproliferative disorder. Exact incidence is unknown and, with its variable clinical presentation, maki... | HYDROXYCHLOROQUINE, METHOTREXATE | DrugsGivenReaction | CC BY-NC-ND | 34094574 | 20,460,493 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Gastroenteritis clostridial'. | Pulmonary lymphomatoid granulomatosis: An uncommon disease but not to be forgotten-a single centre experience.
Pulmonary lymphomatoid granulomatosis (PLG) is a rare multisystem Epstein-Barr virus (EBV)-associated lymphoproliferative disorder. Exact incidence is unknown and, with its variable clinical presentation, maki... | AZITHROMYCIN, CEFTRIAXONE, HYDROCORTISONE, METHYLPREDNISOLONE, PIPERACILLIN SODIUM\TAZOBACTAM SODIUM, VANCOMYCIN | DrugsGivenReaction | CC BY-NC-ND | 34094574 | 20,483,428 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pneumonitis'. | Pulmonary lymphomatoid granulomatosis: An uncommon disease but not to be forgotten-a single centre experience.
Pulmonary lymphomatoid granulomatosis (PLG) is a rare multisystem Epstein-Barr virus (EBV)-associated lymphoproliferative disorder. Exact incidence is unknown and, with its variable clinical presentation, maki... | CYCLOPHOSPHAMIDE, DOXORUBICIN, HYDROCORTISONE, METHOTREXATE, METHYLPREDNISOLONE, MYCOPHENOLIC ACID, PREDNISOLONE, RITUXIMAB, VINCRISTINE | DrugsGivenReaction | CC BY-NC-ND | 34094574 | 20,460,491 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pulmonary granuloma'. | Pulmonary lymphomatoid granulomatosis: An uncommon disease but not to be forgotten-a single centre experience.
Pulmonary lymphomatoid granulomatosis (PLG) is a rare multisystem Epstein-Barr virus (EBV)-associated lymphoproliferative disorder. Exact incidence is unknown and, with its variable clinical presentation, maki... | AZITHROMYCIN, CEFTRIAXONE, HYDROCORTISONE, HYDROXYCHLOROQUINE, METHOTREXATE, PIPERACILLIN SODIUM\TAZOBACTAM SODIUM, VANCOMYCIN | DrugsGivenReaction | CC BY-NC-ND | 34094574 | 20,457,645 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Respiratory syncytial virus infection'. | Pulmonary lymphomatoid granulomatosis: An uncommon disease but not to be forgotten-a single centre experience.
Pulmonary lymphomatoid granulomatosis (PLG) is a rare multisystem Epstein-Barr virus (EBV)-associated lymphoproliferative disorder. Exact incidence is unknown and, with its variable clinical presentation, maki... | HYDROXYCHLOROQUINE, METHOTREXATE | DrugsGivenReaction | CC BY-NC-ND | 34094574 | 20,460,493 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Rhinovirus infection'. | Pulmonary lymphomatoid granulomatosis: An uncommon disease but not to be forgotten-a single centre experience.
Pulmonary lymphomatoid granulomatosis (PLG) is a rare multisystem Epstein-Barr virus (EBV)-associated lymphoproliferative disorder. Exact incidence is unknown and, with its variable clinical presentation, maki... | HYDROXYCHLOROQUINE, METHOTREXATE | DrugsGivenReaction | CC BY-NC-ND | 34094574 | 20,460,493 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Streptococcal infection'. | Pulmonary lymphomatoid granulomatosis: An uncommon disease but not to be forgotten-a single centre experience.
Pulmonary lymphomatoid granulomatosis (PLG) is a rare multisystem Epstein-Barr virus (EBV)-associated lymphoproliferative disorder. Exact incidence is unknown and, with its variable clinical presentation, maki... | CYCLOPHOSPHAMIDE, DOXORUBICIN, HYDROCORTISONE, METHOTREXATE, METHYLPREDNISOLONE, MYCOPHENOLIC ACID, PREDNISOLONE, RITUXIMAB, VINCRISTINE | DrugsGivenReaction | CC BY-NC-ND | 34094574 | 20,460,491 | 2021-07 |
What was the administration route of drug 'METHOTREXATE'? | Pulmonary lymphomatoid granulomatosis: An uncommon disease but not to be forgotten-a single centre experience.
Pulmonary lymphomatoid granulomatosis (PLG) is a rare multisystem Epstein-Barr virus (EBV)-associated lymphoproliferative disorder. Exact incidence is unknown and, with its variable clinical presentation, maki... | Intrathecal | DrugAdministrationRoute | CC BY-NC-ND | 34094574 | 20,456,546 | 2021-07 |
What was the administration route of drug 'VANCOMYCIN'? | Pulmonary lymphomatoid granulomatosis: An uncommon disease but not to be forgotten-a single centre experience.
Pulmonary lymphomatoid granulomatosis (PLG) is a rare multisystem Epstein-Barr virus (EBV)-associated lymphoproliferative disorder. Exact incidence is unknown and, with its variable clinical presentation, maki... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 34094574 | 20,460,494 | 2021-07 |
What was the dosage of drug 'METHYLPREDNISOLONE'? | Pulmonary lymphomatoid granulomatosis: An uncommon disease but not to be forgotten-a single centre experience.
Pulmonary lymphomatoid granulomatosis (PLG) is a rare multisystem Epstein-Barr virus (EBV)-associated lymphoproliferative disorder. Exact incidence is unknown and, with its variable clinical presentation, maki... | UNK, PULSE THERAPY | DrugDosageText | CC BY-NC-ND | 34094574 | 20,460,494 | 2021-07 |
What was the outcome of reaction 'Angiocentric lymphoma'? | Pulmonary lymphomatoid granulomatosis: An uncommon disease but not to be forgotten-a single centre experience.
Pulmonary lymphomatoid granulomatosis (PLG) is a rare multisystem Epstein-Barr virus (EBV)-associated lymphoproliferative disorder. Exact incidence is unknown and, with its variable clinical presentation, maki... | Fatal | ReactionOutcome | CC BY-NC-ND | 34094574 | 20,456,618 | 2021-07 |
What was the outcome of reaction 'Clostridium difficile infection'? | Pulmonary lymphomatoid granulomatosis: An uncommon disease but not to be forgotten-a single centre experience.
Pulmonary lymphomatoid granulomatosis (PLG) is a rare multisystem Epstein-Barr virus (EBV)-associated lymphoproliferative disorder. Exact incidence is unknown and, with its variable clinical presentation, maki... | Not recovered | ReactionOutcome | CC BY-NC-ND | 34094574 | 20,469,341 | 2021-07 |
What was the outcome of reaction 'Disease progression'? | Pulmonary lymphomatoid granulomatosis: An uncommon disease but not to be forgotten-a single centre experience.
Pulmonary lymphomatoid granulomatosis (PLG) is a rare multisystem Epstein-Barr virus (EBV)-associated lymphoproliferative disorder. Exact incidence is unknown and, with its variable clinical presentation, maki... | Fatal | ReactionOutcome | CC BY-NC-ND | 34094574 | 20,483,428 | 2021-07 |
What was the outcome of reaction 'Drug ineffective for unapproved indication'? | Pulmonary lymphomatoid granulomatosis: An uncommon disease but not to be forgotten-a single centre experience.
Pulmonary lymphomatoid granulomatosis (PLG) is a rare multisystem Epstein-Barr virus (EBV)-associated lymphoproliferative disorder. Exact incidence is unknown and, with its variable clinical presentation, maki... | Fatal | ReactionOutcome | CC BY-NC-ND | 34094574 | 20,467,340 | 2021-07 |
What was the outcome of reaction 'Drug ineffective'? | Pulmonary lymphomatoid granulomatosis: An uncommon disease but not to be forgotten-a single centre experience.
Pulmonary lymphomatoid granulomatosis (PLG) is a rare multisystem Epstein-Barr virus (EBV)-associated lymphoproliferative disorder. Exact incidence is unknown and, with its variable clinical presentation, maki... | Fatal | ReactionOutcome | CC BY-NC-ND | 34094574 | 20,460,494 | 2021-07 |
What was the outcome of reaction 'Gastroenteritis'? | Pulmonary lymphomatoid granulomatosis: An uncommon disease but not to be forgotten-a single centre experience.
Pulmonary lymphomatoid granulomatosis (PLG) is a rare multisystem Epstein-Barr virus (EBV)-associated lymphoproliferative disorder. Exact incidence is unknown and, with its variable clinical presentation, maki... | Not recovered | ReactionOutcome | CC BY-NC-ND | 34094574 | 20,469,341 | 2021-07 |
What was the outcome of reaction 'Pulmonary granuloma'? | Pulmonary lymphomatoid granulomatosis: An uncommon disease but not to be forgotten-a single centre experience.
Pulmonary lymphomatoid granulomatosis (PLG) is a rare multisystem Epstein-Barr virus (EBV)-associated lymphoproliferative disorder. Exact incidence is unknown and, with its variable clinical presentation, maki... | Fatal | ReactionOutcome | CC BY-NC-ND | 34094574 | 20,457,645 | 2021-07 |
What was the outcome of reaction 'Respiratory failure'? | Pulmonary lymphomatoid granulomatosis: An uncommon disease but not to be forgotten-a single centre experience.
Pulmonary lymphomatoid granulomatosis (PLG) is a rare multisystem Epstein-Barr virus (EBV)-associated lymphoproliferative disorder. Exact incidence is unknown and, with its variable clinical presentation, maki... | Fatal | ReactionOutcome | CC BY-NC-ND | 34094574 | 20,456,618 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Accidental exposure to product by child'. | Flecainide Toxicity Secondary to Accidental Overdose: A Pediatric Case Report of Two Brothers.
Flecainide is a class 1C antiarrhythmic with a narrow therapeutic window and thereby a high-risk medication for causing acute toxicity. Dysrhythmias secondary to flecainide ingestion are often refractory to antiarrhythmics an... | FLECAINIDE | DrugsGivenReaction | CC BY | 34094603 | 19,239,735 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Accidental overdose'. | Flecainide Toxicity Secondary to Accidental Overdose: A Pediatric Case Report of Two Brothers.
Flecainide is a class 1C antiarrhythmic with a narrow therapeutic window and thereby a high-risk medication for causing acute toxicity. Dysrhythmias secondary to flecainide ingestion are often refractory to antiarrhythmics an... | FLECAINIDE | DrugsGivenReaction | CC BY | 34094603 | 19,239,735 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Agitation'. | Flecainide Toxicity Secondary to Accidental Overdose: A Pediatric Case Report of Two Brothers.
Flecainide is a class 1C antiarrhythmic with a narrow therapeutic window and thereby a high-risk medication for causing acute toxicity. Dysrhythmias secondary to flecainide ingestion are often refractory to antiarrhythmics an... | FLECAINIDE | DrugsGivenReaction | CC BY | 34094603 | 19,239,735 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Bradycardia'. | Flecainide Toxicity Secondary to Accidental Overdose: A Pediatric Case Report of Two Brothers.
Flecainide is a class 1C antiarrhythmic with a narrow therapeutic window and thereby a high-risk medication for causing acute toxicity. Dysrhythmias secondary to flecainide ingestion are often refractory to antiarrhythmics an... | FLECAINIDE | DrugsGivenReaction | CC BY | 34094603 | 19,458,930 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Electrocardiogram QRS complex abnormal'. | Flecainide Toxicity Secondary to Accidental Overdose: A Pediatric Case Report of Two Brothers.
Flecainide is a class 1C antiarrhythmic with a narrow therapeutic window and thereby a high-risk medication for causing acute toxicity. Dysrhythmias secondary to flecainide ingestion are often refractory to antiarrhythmics an... | FLECAINIDE | DrugsGivenReaction | CC BY | 34094603 | 19,239,735 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Electrocardiogram QRS complex prolonged'. | Flecainide Toxicity Secondary to Accidental Overdose: A Pediatric Case Report of Two Brothers.
Flecainide is a class 1C antiarrhythmic with a narrow therapeutic window and thereby a high-risk medication for causing acute toxicity. Dysrhythmias secondary to flecainide ingestion are often refractory to antiarrhythmics an... | ISOPROTERENOL | DrugsGivenReaction | CC BY | 34094603 | 19,656,858 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Haemodynamic instability'. | Flecainide Toxicity Secondary to Accidental Overdose: A Pediatric Case Report of Two Brothers.
Flecainide is a class 1C antiarrhythmic with a narrow therapeutic window and thereby a high-risk medication for causing acute toxicity. Dysrhythmias secondary to flecainide ingestion are often refractory to antiarrhythmics an... | FLECAINIDE | DrugsGivenReaction | CC BY | 34094603 | 19,239,735 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypoperfusion'. | Flecainide Toxicity Secondary to Accidental Overdose: A Pediatric Case Report of Two Brothers.
Flecainide is a class 1C antiarrhythmic with a narrow therapeutic window and thereby a high-risk medication for causing acute toxicity. Dysrhythmias secondary to flecainide ingestion are often refractory to antiarrhythmics an... | FLECAINIDE | DrugsGivenReaction | CC BY | 34094603 | 19,458,891 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypotension'. | Flecainide Toxicity Secondary to Accidental Overdose: A Pediatric Case Report of Two Brothers.
Flecainide is a class 1C antiarrhythmic with a narrow therapeutic window and thereby a high-risk medication for causing acute toxicity. Dysrhythmias secondary to flecainide ingestion are often refractory to antiarrhythmics an... | FLECAINIDE | DrugsGivenReaction | CC BY | 34094603 | 19,458,930 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Mental status changes'. | Flecainide Toxicity Secondary to Accidental Overdose: A Pediatric Case Report of Two Brothers.
Flecainide is a class 1C antiarrhythmic with a narrow therapeutic window and thereby a high-risk medication for causing acute toxicity. Dysrhythmias secondary to flecainide ingestion are often refractory to antiarrhythmics an... | FLECAINIDE | DrugsGivenReaction | CC BY | 34094603 | 19,458,930 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Flecainide Toxicity Secondary to Accidental Overdose: A Pediatric Case Report of Two Brothers.
Flecainide is a class 1C antiarrhythmic with a narrow therapeutic window and thereby a high-risk medication for causing acute toxicity. Dysrhythmias secondary to flecainide ingestion are often refractory to antiarrhythmics an... | CALCIUM, EGG PHOSPHOLIPIDS\SAFFLOWER OIL\SOYBEAN OIL, MAGNESIUM, POTASSIUM, SODIUM BICARBONATE | DrugsGivenReaction | CC BY | 34094603 | 19,772,222 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Overdose'. | Flecainide Toxicity Secondary to Accidental Overdose: A Pediatric Case Report of Two Brothers.
Flecainide is a class 1C antiarrhythmic with a narrow therapeutic window and thereby a high-risk medication for causing acute toxicity. Dysrhythmias secondary to flecainide ingestion are often refractory to antiarrhythmics an... | FLECAINIDE | DrugsGivenReaction | CC BY | 34094603 | 19,458,930 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Seizure like phenomena'. | Flecainide Toxicity Secondary to Accidental Overdose: A Pediatric Case Report of Two Brothers.
Flecainide is a class 1C antiarrhythmic with a narrow therapeutic window and thereby a high-risk medication for causing acute toxicity. Dysrhythmias secondary to flecainide ingestion are often refractory to antiarrhythmics an... | FLECAINIDE | DrugsGivenReaction | CC BY | 34094603 | 19,458,930 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Tachycardia'. | Flecainide Toxicity Secondary to Accidental Overdose: A Pediatric Case Report of Two Brothers.
Flecainide is a class 1C antiarrhythmic with a narrow therapeutic window and thereby a high-risk medication for causing acute toxicity. Dysrhythmias secondary to flecainide ingestion are often refractory to antiarrhythmics an... | FLECAINIDE | DrugsGivenReaction | CC BY | 34094603 | 19,458,930 | 2021 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.